In terms of strengths, the current study is the first attempt to survey the interaction between PON1 rs662 polymorphism and antioxidant vitamins E and C on CAD severity and lipid profile that helps to prescribe personalized nutritional recommendations for the improvement and management of CVD risk in the future. This evidence concerns the gene PON1 and coronary artery disorder.